115 related articles for article (PubMed ID: 26436484)
41. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].
Jiang M; Ma JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002
[TBL] [Abstract][Full Text] [Related]
42. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
[TBL] [Abstract][Full Text] [Related]
43. [Pulmonary function in first generation children of chronic obstructive pulmonary disease (COPD) patients: assessment of related predicting factors].
Lu B; He Q; Chen Q; Huang X; Li J
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1136-9. PubMed ID: 12425829
[TBL] [Abstract][Full Text] [Related]
44. The role of mean platelet volume as an inflammatory marker in children with chronic spontaneous urticaria.
Akelma AZ; Mete E; Cizmeci MN; Kanburoglu MK; Malli DD; Bozkaya D
Allergol Immunopathol (Madr); 2015; 43(1):10-3. PubMed ID: 23969073
[TBL] [Abstract][Full Text] [Related]
45. Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease.
Kristan SS; Marc MM; Kern I; Flezar M; Suskovic S; Kosnik M; Korosec P
Scand J Immunol; 2012 Jan; 75(1):109-14. PubMed ID: 21916917
[TBL] [Abstract][Full Text] [Related]
46. Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial.
Neukamm A; Høiseth AD; Einvik G; Lehmann S; Hagve TA; Søyseth V; Omland T
J Intern Med; 2015 Jul; 278(1):59-67. PubMed ID: 25495178
[TBL] [Abstract][Full Text] [Related]
47. Complement factor C5a in acute exacerbation of Chronic Obstructive Pulmonary Disease.
Marc MM; Kristan SS; Rozman A; Kern I; Flezar M; Kosnik M; Korosec P
Scand J Immunol; 2010 May; 71(5):386-91. PubMed ID: 20500690
[TBL] [Abstract][Full Text] [Related]
48. Markers of disease severity in chronic obstructive pulmonary disease.
Franciosi LG; Page CP; Celli BR; Cazzola M; Walker MJ; Danhof M; Rabe KF; Della Pasqua OE
Pulm Pharmacol Ther; 2006; 19(3):189-99. PubMed ID: 16019244
[TBL] [Abstract][Full Text] [Related]
49. Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation.
Stanojkovic I; Kotur-Stevuljevic J; Milenkovic B; Spasic S; Vujic T; Stefanovic A; Llic A; Ivanisevic J
Respir Med; 2011 Oct; 105 Suppl 1():S31-7. PubMed ID: 22015083
[TBL] [Abstract][Full Text] [Related]
50. Circulating visfatin in chronic obstructive pulmonary disease.
Liu X; Ji Y; Chen J; Li S; Luo F
Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
[TBL] [Abstract][Full Text] [Related]
51. Mean platelet volume is associated with aortic arterial stiffness in patients with Behçet's disease without significant cardiovascular involvement.
Balta I; Balta S; Koryurek OM; Demirkol S; Celik T; Akbay G; Cakar M; Sarlak H; Eksioglu M
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1388-93. PubMed ID: 24164056
[TBL] [Abstract][Full Text] [Related]
52. Factor analysis in predominantly severe COPD: identification of disease heterogeneity by easily measurable characteristics.
Postma DS; Anzueto AR; Jenkins C; Make BJ; Similowski T; Östlund O; Eriksson GS; Calverley PM
Respir Med; 2013 Dec; 107(12):1939-47. PubMed ID: 23953956
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
Grootendorst DC; Gauw SA; Benschop N; Sterk PJ; Hiemstra PS; Rabe KF
Pulm Pharmacol Ther; 2003; 16(6):341-7. PubMed ID: 14580925
[TBL] [Abstract][Full Text] [Related]
54. CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.
Rennard SI; Dale DC; Donohue JF; Kanniess F; Magnussen H; Sutherland ER; Watz H; Lu S; Stryszak P; Rosenberg E; Staudinger H
Am J Respir Crit Care Med; 2015 May; 191(9):1001-11. PubMed ID: 25695403
[TBL] [Abstract][Full Text] [Related]
55. Antioxidant vitamins (A, C and E) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease.
Tug T; Karatas F; Terzi SM
Clin Invest Med; 2004 Jun; 27(3):123-8. PubMed ID: 15305803
[TBL] [Abstract][Full Text] [Related]
56. Could mean platelet volume among complete blood count parameters be a surrogate marker of metabolic syndrome in pre-pubertal children?
Aypak C; Türedi O; Bircan MA; Yüce A
Platelets; 2014; 25(6):393-8. PubMed ID: 23972029
[TBL] [Abstract][Full Text] [Related]
57. Decreased mean platelet volume in children with acute rotavirus gastroenteritis.
Mete E; Akelma AZ; Cizmeci MN; Bozkaya D; Kanburoglu MK
Platelets; 2014; 25(1):51-4. PubMed ID: 23402274
[TBL] [Abstract][Full Text] [Related]
58. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance?
Breyer MK; Spruit MA; Celis AP; Rutten EP; Janssen PP; Wouters EF;
Clin Nutr; 2009 Dec; 28(6):642-7. PubMed ID: 19540024
[TBL] [Abstract][Full Text] [Related]
59. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
Breyer MK; Rutten EP; Locantore NW; Watkins ML; Miller BE; Wouters EF;
Eur J Clin Invest; 2012 Sep; 42(9):983-91. PubMed ID: 22703238
[TBL] [Abstract][Full Text] [Related]
60. Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions.
Korniluk A; Koper-Lenkiewicz OM; Kamińska J; Kemona H; Dymicka-Piekarska V
Mediators Inflamm; 2019; 2019():9213074. PubMed ID: 31148950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
